Onemednet Corp (ONMD) Stock AnalysisONMDOnemednet Corp

OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets. It operates in the Industrials sector (COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH industry).

Currently, Onemednet Corp (ONMD) is not a strong buy. The stock is trading at $4.28, which is significantly down 64.92% year-to-date and 75.82% over the past year. The RSI is at 36.578, indicating that the stock is nearing oversold territory, but it has not yet turned bullish. Additionally, the forward P/E ratio is 0, suggesting uncertainty in future earnings. While insider buying has increased by 100% over the last month, indicating some confidence from management, the overall financial performance remains weak with a gross margin of only 18.52% in the last quarter and a net income loss of $2.17 million in Q2 2026. The main risk is the company's current liabilities, which are still high at $4.73 million compared to its current assets of $1.31 million, leading to a current ratio of only 0.28. Therefore, it may be prudent to hold off on purchasing until clearer signs of recovery emerge.